Professor Investigates Stabilization of Protein-based Medications
May 4, 2012
This year, an estimated 8,880 Utah residents will be diagnosed with cancer, according to the Huntsman Cancer Foundation. When you include friends and loved ones of patients, the number of individuals affected by cancer is much larger. The research of Professor Josh Price, of the Department of Chemistry and Biochemistry, is aimed at reducing that impact by enhancing the effectiveness of pharmaceutical drugs like those used to treat breast cancer and glaucoma.
Price, whose work at BYU focuses on protein structure and folding, began this line of research during his postdoctoral fellowship at The Scripps Research Institute. He recently published two articles on protein folding guidelines that could further stabilize and increase effectiveness of certain pharmaceutical drugs.